AUG 27, 2018 08:56 PM PDT

Anemic Drug Re-purposed To Treat Heart Failure in Diabetics

WRITTEN BY: Nouran Amin

According to a study funded by the British Heart Foundation (BHF) and Diabetes UK, drugs in development to treat anemia can now be repurposed to help prevent people with Type 2 diabetes from heart failure. The study was published in the Journal of American Cardiology and discusses how a protein by the name of HIF was found to help cardiomyocytes (heart cells) thrive after a heart attack.

In diabetics, fats aggregate within the heart muscle and cause the activity of the HIF protein to be inhibited. In other words, a diabetic will then be more likely to suffer a lasting heart muscle damage and develop heart failure after a heart attack. "After a heart attack, people with Type 2 diabetes are more likely to develop heart failure more quickly, but we have not fully understood the reasons why that is the case,” explains Dr. Lisa Heather, a BHF researcher from the University of Oxford and lead author of the study.

When scientists from the University of Oxford treated diabetic rats with a compound responsible for activating the HIF protein, they were motivated to help the heart heal after a heart attack. However, this is not definitive as plenty of research is needed to see if this process is possible to replicate in humans. the heart to recover from a heart attack. Further work is needed to see whether the same process can be replicated in people.

"What we have shown with this research is that the metabolism of people with Type 2 diabetes means they have higher levels of fatty acids in the heart. This prevents signals going to the heart protective protein telling it to 'kick-in' after a heart attack. But what is perhaps most exciting, is that existing drugs -- currently being trialed for people with blood disorders -- can reverse that effect and allow the protein to be activated after a heart attack. This opens the possibility that, in the near future, we could also use these drugs to help treat heart attacks in people with Type 2 diabetes."

Watch this video below to understand more on the relationship between diabetes and the heart!

Source: British Heart Foundation

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 19, 2019
Drug Discovery & Development
NOV 19, 2019
Does TruBrain Really Work?
TruBrain is a mix of different substances claimed to help people increase verbal fluency, avoid distractions, and boost their mental output. Created by a t...
NOV 19, 2019
Genetics & Genomics
NOV 19, 2019
Non-Invasive Gene Therapy Holds Promise for Treating Blindness
Researchers at John Hopkins Medicine have found a way to deliver sight-saving gene therapy to the retina. Having already shown success in treating rates, p...
NOV 19, 2019
Drug Discovery & Development
NOV 19, 2019
Diabetes: The next-generation therapy
A publication in Nature Communications describes a therapeutic that can avoid the side-effects of insulin in diabetic treatments particularly hypoglycemia....
NOV 19, 2019
Drug Discovery & Development
NOV 19, 2019
Metformin Offers No Muscle Mass Gain for Older Adults
A clinical trial initiated by Researchers at the University of Kentucky began a clinical study to address the long-held hypothesis that metformin, the diab...
NOV 19, 2019
Drug Discovery & Development
NOV 19, 2019
Developing Animal-Free Neurotoxin Testing
The need to assess a group of deadly neurotoxins without turning to animal-testing may soon be a possibility. A new animal-free testing technique was recen...
NOV 19, 2019
Drug Discovery & Development
NOV 19, 2019
FDA Approves New Drug for Sickle Cell Disease
Sickle cell disease affects approximately 100,000 Americans. Currently, the only available cure for the disease is a costly bone marrow transplant, putting...
Loading Comments...